Pathos AI raises $237 million at reported $3 billion valuation
Bristol Myers Squibb led Pathos AI’s Series E. The round was smaller than its 2025 financing, while its reported post-money valuation was higher.
Bristol Myers Squibb led Pathos AI’s Series E. The round was smaller than its 2025 financing, while its reported post-money valuation was higher.